• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗高血压药物的各种组合:老年患者的比较评估]

[Various combinations of antihypertensive drugs: comparative assessment in elderly patients].

作者信息

Simonenko V B, Aref'ev E Iu

出版信息

Klin Med (Mosk). 1998;76(6):45-7.

PMID:9693501
Abstract

68 elderly patients with hypertension stage II were treated with different combinations of antihypertensive drugs. 36 patients of group 1 received inhibitors of angiotension-converting enzyme (captopril) and calcium antagonists of prolonged action (adalat CL). 32 patients of group 2 received captopril and beta-blockers (atenolol). The patients were followed up for 12 months. Before and after the treatment the patients underwent 24-h monitoring of arterial pressure and echocardiography. The antihypertensive effect was more pronounced in group 1. Both combinations of the antihypertensive drugs prevented development and progression of myocardial hypertrophy due to hypertension. No significant changes in left ventricular contractility in response to these drug combinations were found.

摘要

68例老年II期高血压患者接受了不同组合的降压药物治疗。第1组36例患者接受血管紧张素转换酶抑制剂(卡托普利)和长效钙拮抗剂(拜心通控释片)治疗。第2组32例患者接受卡托普利和β受体阻滞剂(阿替洛尔)治疗。对患者进行了12个月的随访。治疗前后对患者进行了24小时动脉压监测和超声心动图检查。第1组的降压效果更为显著。两种降压药物组合均能预防高血压所致心肌肥厚的发生和进展。未发现这些药物组合对左心室收缩力有显著影响。

相似文献

1
[Various combinations of antihypertensive drugs: comparative assessment in elderly patients].[抗高血压药物的各种组合:老年患者的比较评估]
Klin Med (Mosk). 1998;76(6):45-7.
2
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.高血压左心室肥厚患者氯沙坦干预降低终点事件(LIFE)研究中的血压降低及降压药物使用情况
Curr Med Res Opin. 2007 Feb;23(2):259-70. doi: 10.1185/030079906X162854.
3
Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.高血压性心脏重塑的纠正:不同降压治疗方法的比较
Med Sci Monit. 2000 Mar-Apr;6(2):309-13.
4
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
5
ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.基于血管紧张素转换酶抑制剂的治疗与2型糖尿病患者的降压效果
Panminerva Med. 2008 Sep;50(3):207-16.
6
Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.血管紧张素转换酶抑制和二氢吡啶类钙通道阻滞在治疗动脉高血压左心室肥厚中的应用
Minerva Cardioangiol. 2002 Jun;50(3):169-74.
7
Antihypertensive drug prescription trends at the primary health care centres in Bahrain.巴林初级卫生保健中心的抗高血压药物处方趋势
Pharmacoepidemiol Drug Saf. 2001 May;10(3):219-27. doi: 10.1002/pds.578.
8
Now or never: optimal antihypertensive therapy in the elderly.机不可失:老年人的优化抗高血压治疗
Prev Cardiol. 2008 Fall;11(4):201-9. doi: 10.1111/j.1751-7141.2008.00005.x.
9
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.老年单纯收缩期高血压患者的心血管事件。STOP-Hypertension-2研究中治疗策略的亚组分析。
Blood Press. 2004;13(3):137-41. doi: 10.1080/08037050410014944.
10
Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.α受体阻滞剂多沙唑嗪作为高血压合并糖代谢受损患者附加治疗的临床疗效及耐受性
Nutr Metab Cardiovasc Dis. 2006 Mar;16(2):137-47. doi: 10.1016/j.numecd.2005.04.005. Epub 2005 Oct 20.